{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:45:34Z","timestamp":1748972734824},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.plabm.2016.12.002","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T18:18:59Z","timestamp":1483640339000},"page":"19-26","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Roche Total Mycophenolic Acid\u00ae assay: An application protocol for the ABX Pentra 400 analyzer and comparison with LC\u2013MS in children with idiopathic nephrotic syndrome"],"prefix":"10.1016","volume":"7","author":[{"given":"Fran\u00e7ois","family":"Parant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claude","family":"Gagnieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.plabm.2016.12.002_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.trre.2013.10.005","article-title":"The role of mycophenolate mofetil in kidney transplantation revisited","volume":"28","author":"Maripuri","year":"2014","journal-title":"Transpl. Rev."},{"key":"10.1016\/j.plabm.2016.12.002_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40262-013-0039-8","article-title":"Clinical Pharmacokinetics and pharmacodynamics of Mycophenolate in patients with autoimmune disease","volume":"52","author":"Rahman","year":"2013","journal-title":"Clin. Pharmacokinet"},{"key":"10.1016\/j.plabm.2016.12.002_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","article-title":"Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial","volume":"27","author":"Baudouin","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00467-016-3400-y","article-title":"Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome","volume":"31","author":"Dehoux","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus ciclosporin for remission maintenance in nephrotic syndrome","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.plabm.2016.12.002_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2215\/CJN.07111009","article-title":"Transplantation Society (TTS) consensus group on TDM of MPA. Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0000000000000223","article-title":"Therapeutic drug monitoring of mycophenolic acid in lupus nephritis: a review of current literature","volume":"37","author":"\u0141uszczy\u0144ska","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","article-title":"Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome","volume":"24","author":"Gellermann","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/FTD.0000000000000258","article-title":"Mycophenolate-mofetil therapy in children with idiopathic nephrotic syndrome. Does therapeutic drug monitoring make a difference?","volume":"38","author":"Hackl","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.phrs.2011.01.009","article-title":"Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome","volume":"63","author":"Saint-Marcoux","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.plabm.2016.12.002_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejps.2015.06.017","article-title":"Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters","volume":"77","author":"Sobiak","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.plabm.2016.12.002_bib13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2215\/CJN.00320116","article-title":"Mycophenolic acid pharmacokinetics and relapse in children with steroid-dependent idiopathic nephrotic syndrome","volume":"11","author":"Tellier","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.plabm.2016.12.002_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/FTD.0b013e3181cc342a","article-title":"Investigation of the crossreactivity of mycophenolic acid glucuronide metabolites and of mycophenolate mofetil in the Cedia MPA assay","volume":"32","author":"Shipkova","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FTD.0b013e3181ba9a0e","article-title":"High-performance liquid chromatography-mass spectroscopy\/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites","volume":"31","author":"Figurski","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/CCLM.1999.067","article-title":"A simple HPLC method for monitoring mycophenolic acid and its glucuronidated metabolite in transplant recipients","volume":"37","author":"Seebacher","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2016.12.002_bib17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007691-200112000-00021","article-title":"Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum","volume":"23","author":"Vogeser","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1002\/lt.21607","article-title":"Comparison of a new enzymatic assay with a high-performance liquid chromatography\/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients","volume":"14","author":"Blanchet","year":"2008","journal-title":"Liver Transplant."},{"key":"10.1016\/j.plabm.2016.12.002_bib19","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/FTD.0b013e31817fd590","article-title":"Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma","volume":"30","author":"Brandhorst","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1515\/CCLM.2005.133","article-title":"Evaluation of the ABX Pentra 400: a newly available clinical chemistry analyser","volume":"43","author":"Coud\u00e8ne","year":"2005","journal-title":"Clin. Chem. Lab. Med."},{"issue":"Suppl 1","key":"10.1016\/j.plabm.2016.12.002_bib21","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.plabm.2016.12.002_bib22","unstructured":"NCCLS document EP5-A2, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline, 2nd ed., Wayne, PA, USA, 2004."},{"key":"10.1016\/j.plabm.2016.12.002_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1515\/cclm-2014-0942","article-title":"Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data","volume":"53","author":"Matar","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2016.12.002_bib24","unstructured":"SH GTA 14, Technical guide for accreditation for the uncertainty measurement assessment in medical biology. \u3008https:\/\/www.cofrac.fr\/documentation\/SH-GTA-14\/\u3009, undated (accessed 04.10.16)."},{"key":"10.1016\/j.plabm.2016.12.002_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","volume":"38","author":"Seger","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-200412000-00005","article-title":"Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring","volume":"26","author":"Premaud","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/FTD.0000000000000151","article-title":"A Comparison of the immunochemical methods, PETINIA and EMIT, with that of HPLC-UV for the routine monitoring of mycophenolic acid in heart transplant patients","volume":"37","author":"Kunicki","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0041-1345(98)01936-8","article-title":"Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite","volume":"31","author":"Shipkova","year":"1999","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.plabm.2016.12.002_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1515\/CCLM.2011.194","article-title":"Performance of the Roche Total Mycophenolic Acid \u00ae assay on the Cobas Integra 400 \u00ae, Cobas 6000 \u00ae and comparison to LC\u2013MS\/MS in liver transplant patients","volume":"49","author":"Decavele","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.plabm.2016.12.002_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/FTD.0b013e3181a8f0ae","article-title":"Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients","volume":"31","author":"Marquet","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.plabm.2016.12.002_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/FTD.0b013e31819a05f2","article-title":"Clinical utility of a new enzymatic assay for determination of mycophenolic acid in comparison with an optimized LC\u2013MS\/MS method","volume":"31","author":"van Gelder","year":"2009","journal-title":"Ther. Drug Monit."}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551716300415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551716300415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T19:47:49Z","timestamp":1658346469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551716300415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"alternative-id":["S2352551716300415"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2016.12.002","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Roche Total Mycophenolic Acid\u00ae assay: An application protocol for the ABX Pentra 400 analyzer and comparison with LC\u2013MS in children with idiopathic nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}